[
1. Rosenblat JD, Gregory JM, Carvalho AF, McIntyre RS. Depression and disturbed bone metabolism: a narrative review of the epidemiological findings and postulated mechanisms. Curr Mol Med 2016; 16(2): 165-78.10.2174/1566524016666160126144303
]Search in Google Scholar
[
2. Cizza G, Primma S, Coyle M, Gourgiotis L, Csako G. Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res 2010; 42(7): 467-82.10.1055/s-0030-1252020
]Search in Google Scholar
[
3. Qiu L, Yang Q, Sun N, Li D, Zhao Y, Li X, et al. Association between depression and the risk for fracture: a meta-analysis and systematic review. BMC Psychiatry 2018; 18(1): 336.10.1186/s12888-018-1909-2
]Search in Google Scholar
[
4. Shi TT, Min M, Zhang Y, Sun CY, Liang MM, Sun YH. Depression and risk of hip fracture: a systematic review and meta-analysis of cohort studies. Osteoporos Int 2019; 30(6): 1157-65.10.1007/s00198-019-04951-6
]Search in Google Scholar
[
5. Van de Ven LI, Klop C, Overbeek JA, De Vries F, Burden AM, Janssen PK. Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands. Osteoporos Int 2018; 29(11): 2477-85.10.1007/s00198-018-4632-4
]Search in Google Scholar
[
6. Calarge CA, Mills JA, Janz KF, Burns TL, Schlechte JA, Coryell WH, et al. The Effect of Depression, Generalized Anxiety, and Selective Serotonin reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults. J Bone Miner Res 2017; 32(12): 2367-74.10.1002/jbmr.3238
]Search in Google Scholar
[
7. Anderson PH. Vitamin D Activity and Metabolism in Bone. Curr Osteoporos Rep 2017; 15(5): 443-9.10.1007/s11914-017-0394-8
]Search in Google Scholar
[
8. Lo Cascio V, Adami S, Tartarotti D, Ferrari S, Zatti M. Aberration in vitamin D metabolism during mianserin treatment. Lancet 1984; 1(8383): 958-9.10.1016/S0140-6736(84)92410-3
]Search in Google Scholar
[
9. Oude Voshaar RC, Derks WJ, Comijs HC, Schoevers RA, De Borst MH, Marijnissen RM. Antidepressants differentially related to 1,25-(OH)2 vitamin D3 and 25- (OH) vitamin D3 in late-life depression. Transl Psychiatry 2014; 4(4): e383.10.1038/tp.2014.14401227924736799
]Search in Google Scholar
[
10. Stanojević Pirković M. Risk factors for disturbances of bone tissue homeostasis in patients with psychotic disorders, Ph.D. Thesis. Faculty of the Medical Sciences University of Kragujevac, Kragujevac (in Serbian), 2012.
]Search in Google Scholar
[
11. Milovanovic D. Population pharmacokinetics of 25- hydroxyvitamin D in students, Ph.D. Thesis, Faculty of Medical Sciences University of Kragujevac, Kragujevac (in Serbian) 2014.
]Search in Google Scholar
[
12. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96(7): 1911-30.10.1210/jc.2011-038521646368
]Search in Google Scholar
[
13. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 2013; 202: 100-7.10.1192/bjp.bp.111.10666623377209
]Search in Google Scholar
[
14. Menon V, Kar SK, Suthar N, Nebhinani N. Vitamin D and Depression: A Critical Appraisal of the Evidence and Future Directions. Indian J Psychol Med 2020; 42(1): 11-21.10.4103/IJPSYM.IJPSYM_160_19697030031997861
]Search in Google Scholar
[
15. Woo YS, Kim S, Jeong JH, Jung YE, Kim MD, Bahk WM. Vitamin D Deficiency/Insufficiency among Inpatients with Depressive Symptoms. Clin Psychopharmacol Neurosci 2019; 17(1): 121-24.10.9758/cpn.2019.17.1.121636104730690947
]Search in Google Scholar
[
16. Bersani FS, Ghezzi F, Maraone A, Vicinanza R, Cavaggioni G, Biondi M, et al. The relationship between Vitamin D and depressive disorders. Riv Psichiatr 2019; 54(6): 229-34.
]Search in Google Scholar
[
17. Briggs R, McCarroll K, O’Halloran A, Healy M, Kenny RA, Laird E. Vitamin D Deficiency Is Associated With an Increased Likelihood of Incident Depression in Community-Dwelling Older Adults. J Am Med Dir Assoc 2019; 20(5): 517-23.10.1016/j.jamda.2018.10.00630470577
]Search in Google Scholar
[
18. Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients 2014; 6(4): 1501-18.10.3390/nu6041501401104824732019
]Search in Google Scholar
[
19. Anjum I, Jaffery SS, Fayyaz M, Samoo Z, Anjum S. The role of vitamin D in brain health: A Mini Literature Review. Cureus 2018; 10(7): e2960.10.7759/cureus.2960613268130214848
]Search in Google Scholar
[
20. IOM (Institute of Medicine): Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DC, 2011.
]Search in Google Scholar
[
21. Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio GM, et al. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets. Pharmacol Rev 2018; 70(3): 475-504.10.1124/pr.117.01497729884653
]Search in Google Scholar
[
22. Ham AC, Aarts N, Noordam R, Rivadeneira F, Ziere G, Zillikens MC, et al. Use of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density Change: A Population-Based Longitudinal Study in Middle-Aged and Elderly Individuals. J Clin Psychopharmacol 2017; 37(5): 524-30.10.1097/JCP.000000000000075628816927
]Search in Google Scholar
[
23. Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, et al. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 2006; 98(1): 139-51.10.1002/jcb.2073416408289
]Search in Google Scholar
[
24. Fraher D, Hodge JM, Collier FM, McMillan JS, Kennedy RL, Ellis M, et al. Citalopram and sertraline exposure compromises embryonic bone development. Mol Psychiatry 2016; 21(5): 656-6410.1038/mp.2015.13526347317
]Search in Google Scholar